A Journal of Physiology study from UC Riverside found that whole cannabis extract reversed the fat-to-pancreas signaling failure behind type 2 diabetes—while purified THC alone did not. The findings suggest the entourage effect may have direct implications at the level of metabolic disease biology, not just symptom management. Dr. Caplan offers clinical perspective on what this means for patients interested in cannabis extract metabolic health applications.
Cannabis compounds may improve metabolism and reduce diabetes risk
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchMetabolic HealthTHCCBDSafety Why This Matters Preclinical evidence that cannabis compounds improve insulin sensitivity and glucose...
What UK Biobank Data Suggests About Cannabis, BMI, Diabetes, and Hypertension
This cannabis metabolic health study analyzed 91,002 UK Biobank participants to explore links between cannabis use, diabetes, hypertension, and obesity risk. Researchers found lower rates of several metabolic conditions among cannabis users, but BMI substantially altered the associations. The findings support a more individualized, endocannabinoid-informed approach to metabolic counseling while reinforcing the limits of observational data.
Cannabidiol Glucose Tolerance Study Evidence Based
Clinical Takeaway In sedentary adults with overweight or obesity, a short course of low-dose CBD did not produce measurable improvements in glucose tolerance or changes to gut bacteria composition. These findings do...
Endocannabinoid System Research: CBD Glucose Study
Clinical Takeaway CBD supplementation at low doses for a short duration did not improve glucose tolerance or alter gut microbiota composition in overweight or obese adults, despite theoretical mechanisms suggesting potential benefit....
How Cannabinoid Signaling Shapes Insulin Sensitivity in Humans
Cannabinoid receptor insulin sensitivity is explored in a controlled human trial using gold-standard metabolic clamp techniques. The findings show that CB1 receptor activity can shift insulin sensitivity without altering insulin secretion. This study adds important mechanistic insight into how the endocannabinoid system interacts with human glucose metabolism.
GLP-1 Receptor Agonist Effects on Muscle Mass (56 characters)
GLP-1 Clinical Relevance #43Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Patient EducationCommentaryWeight LossGLP-1 Receptor AgonistPrimary CareAdults with ObesityMuscle Mass PreservationAppetite RegulationLean Body MassSarcopenia RiskNon-Pharmacologic Weight...
OM CBD vegan gummies for metabolic balance and daily wellness
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic CbdMetabolic HealthWellness ProductsProduct QualityPatient Education Why This MattersCommercial CBD wellness products continue to proliferate...
GLP-1 Diabetes Cardiovascular Outcomes: Clinical Evidence
GLP-1 Clinical Relevance #52Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical CommentaryObservational StudyType 2 DiabetesGLP-1 Receptor AgonistEndocrinologyAdults with ObesityCardiovascular OutcomesInsulin ResistanceRapid Weight...
GLP-1 Receptor Agonist Benefits for Women’s Health
GLP-1 Clinical Relevance #41Contextual Information Background context; limited direct clinical applicability. ⚕ GLP-1 News | CED Clinic Clinical CommentaryObservationalObesity TreatmentGLP-1 Receptor AgonistWomen’s HealthAdult WomenWeight ManagementAppetite RegulationMetabolic HealthHormonal InteractionsCardiovascular Risk ReductionLong-Term Care Why...